Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Richard D. Sweet"'
Publikováno v:
Clinical Pharmacology & Therapeutics. 16:1077-1082
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0134b48b1a419f2c94ce7e7a741306e3
https://doi.org/10.1002/cpt19741661077
https://doi.org/10.1002/cpt19741661077
Publikováno v:
Archives of Neurology. 32:560-563
Irregularities in motor response after continuing levodopa therapy of Parkinson disease (the "on-off effect") were assessed with the addition of L-alpha-methyldopa hydrazine (carbidopa) in a double-blind study. Thirteen of 20 patients improved while
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41825960741ed7c5c585e44f01e601e3
https://doi.org/10.1001/archneur.1975.00490500080010
https://doi.org/10.1001/archneur.1975.00490500080010
Publikováno v:
Clinical Neuropharmacology. 1:81-106
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a704a294cf4bf6e15c605d4871d9020a
https://doi.org/10.1097/00002826-197600010-00006
https://doi.org/10.1097/00002826-197600010-00006
Autor:
Ruth D. Bruun, Henrietfe Wayne, Elaine Shapiro, Richard D. Sweet, Gail E. Solomon, Arthur K. Shapiro
Publikováno v:
American Journal of Psychiatry. 133:944-947
The authors conducted a follow-up study of 78 patients with Gilles de la Tourette's syndrome. Four of the patients were in spontaneous remission; 59 patients taking haloperidol showed an average improvement of 79.3% and the remaining patients, 3 of w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eec443b7c8dbce9a05502939832e8cca
https://doi.org/10.1176/ajp.133.8.944
https://doi.org/10.1176/ajp.133.8.944
Autor:
Donald J. Reis, Richard D. Sweet
Publikováno v:
Brain Research. 33:584-588
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b691f3ddcb85bf5679dcce2ed720144
https://doi.org/10.1016/0006-8993(71)90144-2
https://doi.org/10.1016/0006-8993(71)90144-2
Publikováno v:
Brain. 95:405-412
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c593907a00bee63380dba9fe8be31165
https://doi.org/10.1093/brain/95.2.405
https://doi.org/10.1093/brain/95.2.405
Publikováno v:
Neurology. 26(5)
Piribedil, a dopamine agonist, was administered to 13 patients with long-standing Parkinson9s disease whose major symptoms were not well controlled on levodopa, anticholinergics, alpha-methyldopa, amantadine, or a combination of these agents. Twelve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e31fed5ccebf64373a41c3f21e408e7c
https://pubmed.ncbi.nlm.nih.gov/944394
https://pubmed.ncbi.nlm.nih.gov/944394
Publikováno v:
Neurology. 27(2)
Eighty-one patients and relatives with Tourette's syndrome, members of 21 selected families, participated in a 1-day clinic. In 12 of the 13 Jewish families and six of the eight non-Jewish families, there were multiple members with motor and vocal ti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22d55607573515568c45e6b134ef34f4
https://pubmed.ncbi.nlm.nih.gov/264605
https://pubmed.ncbi.nlm.nih.gov/264605
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 68(9)
Human erythrocytes have been found to contain appreciable amounts of DOPA decarboxylase (EC 4.1.1.26) activity. The enzyme activity in erythrocytes from patients with Parkinson's disease who were treated with DOPA was significantly lower than that of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f5f65a7928e36490a894a3b62d4f828
https://pubmed.ncbi.nlm.nih.gov/5289372
https://pubmed.ncbi.nlm.nih.gov/5289372
Clinical neurological examinations of 22 patients with Gilles de la Tourette's syndrome and written reports of examinations of seven other patients are reported. Half the personally examined patients had minor motor asymmetries in addition to the typ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee51d6b79dea881bbf8a9eea716b2a3
https://europepmc.org/articles/PMC494268/
https://europepmc.org/articles/PMC494268/
